Award
Delivery Order #SPE2D326F287H
Pfizer Delivery Order for Lidocaine Injection Vials
Buyer
Defense Logistics Agency
Award Amount
$100.00
Ceiling
$100.00
Awarded
July 22, 2026
Period of Performance
Jul 22, 2026 – Jul 23, 2026
Identifier
SPE2D326F287H
NAICS
325412
This delivery order under the Defense Logistics Agency’s existing indefinite-delivery contract directs Pfizer Inc. to supply lidocaine hydrochloride 2% in 20 mL vials. Pfizer is a pharmaceutical manufacturer and distributor; its parent company is not identified in the available data. The order supports access to injectable medication for government medical needs, with performance in New York. It is linked to a competitively awarded parent contract covering pharmaceutical supplies, although the order-level competition method and solicitation details are not provided. The parent contract is a long-term vehicle for medicines and related medical products. This order has a very short performance window and was scheduled for fulfillment in July 2026. No acquisition program, subcontractor, or other related prior contract information is available beyond the parent contract.
Description
4572451646!LIDOCAINE HCL 2% VIAL 20ML